US Patent Issued to Vital Connect on Nov. 4 for "Screening device, method, and system for structural heart disease" (California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,288, issued on Nov. 4, was assigned to Vital Connect Inc. (San Jose, Calif.).

"Screening device, method, and system for structural heart disease" was invented by Gabriel Nallathambi (San Jose, Calif.), Ben Alexander (San Jose, Calif.) and Nandakumar Selvaraj (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A wireless wearable sensor device, system, method, and non-transitory computer readable medium for screening for structural heart disease based on electrocardiogram, phonocardiogram, and/or accelerometer signals on a patient's skin surface."

The patent was filed on Nov. 30, 2022, under Application No. 18/072,122.

*For further info...